Boston Scientific has signed a deal to acquire the maker of a chemotherapy infusion pump aimed at treating certain inoperable ...

Intera’s portfolio consists of Intera 3000 Hepatic Artery Infusion Pump, which is used to administer chemotherapy in liver ...

Boston Scientific Corporation BSX has entered into a definitive agreement to acquire Intera Oncology Inc., a Boston-based life science company. The acquisition expands the company’s interventional ...

Boston Scientific (NYSE:BSX) announced today that it agreed to acquire infusion pump maker Intera Oncology for an undisclosed ...

Key drivers include chronic conditions and an ageing population. An increasing prevalence of chronic diseases is expected to ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Intera Oncology, a privately held ...

Boston Scientific Corp. (BSX) announced Monday it has entered into a definitive agreement to acquire Intera Oncology Inc., a ...

Dr. Katherine Poruk, a surgical oncologist at Mayo Clinic, says a specialized therapy known as hepatic artery infusion pump (HAIP) chemotherapy is an option for some. HAIP therapy targets tumors ...

Developed in 2010, the Regenstrief National Center for Medical Device Informatics (REMEDI) is a flagship software solution that collects infusion pump data from a broad range of manufacturers. REMEDI ...

With more than 325,000 pumps installed worldwide, the Plum A+™ general purpose infusion system remains the proven choice for caregivers and clinicians alike. The scalable platform can be ...

"Rising Chronic Disease Cases and Advancements in Medical Technology Drive Rapid Growth in the Infusion Pump Market" BOSTON, Nov. 8, 2024 /PRNewswire/ -- "According to the latest study from BCC ...